Hospital of Jaseng Oriental Medicine wins USA product patent for Sinvarometin

Published: 2003-07-04 06:58:00

Updated: 2003-07-04 06:58:00

The Central Disc Center at Hospital of Jaseng Oriental Medicines said it won a U.S. product patient (No. 6,531,582B1) related to Sinvarometin, a novel herbal compound extracted from its Chuna therapy (combinations of several herbs).

With the product patent acquisition in the U.S., the efficac...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK